Reneo Pharmaceuticals, Inc.

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

75974E103

SEDOL

N/A

CIK

0001637715

reneopharma.com

LEI:

FIGI: BBG00JVRSRC1

RPHM

Reneo Pharmaceuticals, Inc.

GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology

PROFILER

NAME

Reneo Pharmaceuticals, Inc.

ISIN

US75974E1038

TICKER

RPHM

MIC

XNAS

REUTERS

RPHM.OQ

BLOOMBERG

RPHM US

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Fri, 04.10.2024

OnKure Announces Closing of Merger with Reneo Pharmaceuticals

Research & Analysis

Thu, 03.10.2024

– Combined company to trade on Nasdaq under ticker “OKUR”

Research & Analysis

Mon, 13.05.2024

Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology

Research & Analysis

Tue, 07.05.2024

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

SMART * AD

P R O D U C T S U G G E S T I O N S

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Reneo Pharmaceuticals, Inc.

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

Newsletter